News
Videos
Conferences
Events
Resources
Subscribe

|Videos|June 22, 2022

Tivozanib: Adverse Event Profile and How Toxicities are Managed

Author(s)Thomas Hutson, DO, PharmD

Dr Thomas Hutson reviews the adverse event profile of tivozanib and provides advice to community oncologists on how to best manage these toxicities.

Episodes in this series

EP. 1 Treatment Options for Patients with Renal Cell Carcinoma (RCC)

EP. 1 Treatment Options for Patients with Renal Cell Carcinoma (RCC)

EP. 2 Clinical Implications of the TIVO-3 Trial

EP. 2 Clinical Implications of the TIVO-3 Trial

EP. 3 Tivozanib: Adverse Event Profile and How Toxicities are Managed

EP. 4 Experience with Tivozanib in the 3rd Line Setting for Patients with RCC

EP. 4 Experience with Tivozanib in the 3rd Line Setting for Patients with RCC

EP. 5 Future Perspectives in Renal Cell Carcinoma (RCC)

EP. 5 Future Perspectives in Renal Cell Carcinoma (RCC)

Newsletter

Stay up to date on cancer updates, research and education

Related Content

The Future of CLL Care: Medical Breakthroughs and Patient-Physician Collaboration

September 20th 2024

Living Well With CLL: Nutrition, Exercise, and Lifestyle Tips From Patients and Doctors

September 20th 2024

Fixed-Duration vs Continuous CLL Therapy: Balancing Efficacy, Quality of Life, and Costs

September 13th 2024

CLL Treatment and Quality of Life: Patient Empowerment and Shared Decision-making

September 13th 2024

LL Treatment Roadmap: Navigating First-Line Options With Your Doctor

September 6th 2024

Trending on CURE

New Combination Treatment Approach Studied in Pancreatic Cancer

Why Is Lung Health Key to Survivorship After Cancer Treatment?

U.S. Soccer Legend Kasey Keller Reveals Lymphoma Journey

Discussing Community and the Importance of World Cancer Day

The Power of Personalized Care in Breast Cancer Treatment